TLD (tenofovir disoproxil, lamivudine, dolutegravir)

No images as many versions are available


TLD is a generic HIV combination. It contains tenofovir disoproxil, lamivudine and dolutegravir.

This combination is only available in either low or middle-income countries. Or in some high-income countries where there are a high percentage of HIV positive people. This is because dolutegravir is still under patent in most high-income countries.

We have not included a picture of TLD because this is manufactured by many different companies.

There are many generic versions of tenofovir DF, lamivudine (3TC) and dolutegravir coformulated into a single pill (TLD).

These include Acriptega, Dovimil, Emdolten, Lanograv, Lavern, Luvigen, Milutin, Nuvaco, Odystra, Ranega, Reydin, Telado, Telatri, Temiv, Tladeez, Viripil and Volutrip.

See this website that includes generics used in South Africa and other countries.

Widely used generic versions of TLD include:

Commercial drug name Generic manufacturer
Acriptega, Odystra, Ranega Mylan Pharma
Dovimil, Luvigen, Milutin Hetero Pharma
Emdolten Aspen Pharma
Kovatrax Activo Health
Lanograv, Telatri Ranbaxy Drugs
Lavern, Temiv Emcure Pharma
Nuvaco AI Pharma
Reydin, Telado Cipla Pharma
Tladeez Kiara Health
Volutrip Aurobindo